National Institute on Aging (NIA)

Purpose

This Notice clarifies four aspects within the Purpose section of NOT-AG-19-007, "Notice of Special Interest: High-Priority Research Topics for PAR-19-071 ."

1. The first sentence of NOT-AG-19-007 is modified to reflect that PAR-19-071 does not accept applications that propose clinical trials.
   • Currently reads:
     • This Notice of Special Interest specifies two high-priority topics of interest for PAR-19-071 "Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional)".
   • Modified to read:
     • This Notice of Special Interest specifies two high-priority topics of interest for PAR-19-071 "Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Not Allowed)".
2. The following sentence is removed from the end of the Purpose section of NOT-AG-19-007: "Applications that either propose clinical trials or do not propose clinical trials may be considered a high priority." PAR-19-071 does not accept applications that propose clinical trials.
3. The Purpose section contains general guidance on use of the Agency Routing Identifier field (box 4B). This Notice adds more specific instructions.
   • Currently reads:
     • Submissions should indicate that they are in response to NOT-AG-19-007 in Field 4.b on the SF 424 form.
   • Modified to read:
     • For funding consideration, applicants must include NOT-AG-19-007 (without quotation marks) in the Agency Routing Identifier field (box 4B) of the SF424 R&R form. Applications without this information in box 4B will not be considered for this initiative.
4. This Notice amends the Purpose section by adding the following sentence:
   • The first application due date relevant to this Notice of Special Interest is July 9, 2019.

All other aspects of NOT-AG-19-007 remain unchanged.

Inquiries

Please direct all inquiries to:

Austin Yang, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-496-9350
Email: [email protected]